Peterson Wealth Services Lowers Stake in HealthEquity, Inc. (NASDAQ:HQY)

Peterson Wealth Services lessened its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 34.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 6,938 shares of the company's stock after selling 3,569 shares during the period. Peterson Wealth Services' holdings in HealthEquity were worth $613,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Ameritas Investment Partners Inc. boosted its holdings in HealthEquity by 0.3% in the fourth quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company's stock valued at $3,248,000 after acquiring an additional 88 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in HealthEquity by 0.6% in the 4th quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,286 shares of the company's stock valued at $1,850,000 after buying an additional 106 shares during the last quarter. Hancock Whitney Corp raised its position in HealthEquity by 1.0% in the 4th quarter. Hancock Whitney Corp now owns 13,326 shares of the company's stock valued at $1,279,000 after buying an additional 133 shares during the last quarter. Xponance Inc. raised its position in HealthEquity by 1.1% in the 1st quarter. Xponance Inc. now owns 12,412 shares of the company's stock valued at $1,097,000 after buying an additional 136 shares during the last quarter. Finally, Level Four Advisory Services LLC increased its position in shares of HealthEquity by 5.3% during the 4th quarter. Level Four Advisory Services LLC now owns 2,736 shares of the company's stock worth $263,000 after purchasing an additional 138 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on HQY shares. The Goldman Sachs Group boosted their price target on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a report on Wednesday, June 4th. Barrington Research boosted their price target on HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a report on Thursday, June 5th. JMP Securities upped their target price on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a report on Wednesday, June 4th. Wall Street Zen raised HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a report on Thursday, June 5th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus price target of $118.55.

Insider Transactions at HealthEquity

In other news, Director Jon Kessler sold 134,183 shares of the business's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the sale, the director directly owned 253,510 shares of the company's stock, valued at $28,413,400.80. The trade was a 34.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael Henry Fiore sold 1,794 shares of the business's stock in a transaction on Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the sale, the executive vice president directly owned 53,225 shares in the company, valued at $5,414,579.25. This trade represents a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 291,744 shares of company stock valued at $32,705,007. 1.50% of the stock is currently owned by company insiders.

HealthEquity Stock Performance

Shares of NASDAQ:HQY traded up $0.33 during midday trading on Tuesday, hitting $97.41. The company had a trading volume of 647,327 shares, compared to its average volume of 870,078. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $116.65. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06. The company has a market cap of $8.42 billion, a price-to-earnings ratio of 71.10, a PEG ratio of 1.51 and a beta of 0.49. The company has a fifty day moving average of $101.65 and a two-hundred day moving average of $98.49.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The business had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. During the same quarter in the prior year, the firm earned $0.80 EPS. On average, equities research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.